Zur Kurzanzeige

The impact of testosterone-lowering medication on recidivism in individuals convicted of sexual offenses

dc.date.accessioned2024-07-09T10:18:49Z
dc.date.available2024-07-09T10:18:49Z
dc.date.issued2024-06-05
dc.identifierdoi:10.17170/kobra-2024070810477
dc.identifier.urihttp://hdl.handle.net/123456789/15902
dc.description.sponsorshipGefördert durch den Publikationsfonds der Universität Kassel
dc.language.isoeng
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAntiandrogenseng
dc.subjectGnRHagonistseng
dc.subjectrecidivism riskeng
dc.subjectparaphilic disordereng
dc.subjectpaedophilic disordereng
dc.subject.ddc150
dc.subject.ddc610
dc.titleThe impact of testosterone-lowering medication on recidivism in individuals convicted of sexual offenseseng
dc.typeAufsatz
dcterms.abstractIntroduction: Treatment of individuals who have committed sexual offences with Testosterone-Lowering Medication (TLM) is a comparatively intrusive kind of intervention, which regularly takes place in coercive contexts. Thus, the question of efficacy, but also the question of who should be treated, when and for how long, are of great importance. Methods: Recidivism rates of TLM-treated high-risk individuals (þTLM; n¼54) were compared with high-risk individuals treated with psychotherapy only in the same forensic outpatient clinic (−TLM; n¼79). Results: Group differences suggested a higher initial risk ofþTLM (e.g. higher ris-assessment, previous convictions). Despite the increased risk, after an average time at risk of six years, þTLM recidivated significantly less often and significantly later than−TLM (27.8% vs. 51.9%). Such an effect was also found for violent (1.9% vs. 15.2%), but not for sexual (5.6% vs. 10.1%) and serious recidivism (5.6% vs. 10.1%), which could be explained partly by the small number of cases. In the course of treatment, TLM proved to be a significant variable for a positive process, whereas a high risk-assessment score indicated a rather negative course. In total, n¼19 individuals had stopped their TLM treatment, of these 31.6% recidivated. Conclusion: The results support the efficacy of TLM, particularly in the group of high-risk offenders.eng
dcterms.accessRightsopen access
dcterms.creatorSauter, Julia
dcterms.creatorLingenti, Laura M.
dcterms.creatorRettenberger, Martin
dcterms.creatorTurner, Daniel
dcterms.creatorBriken, Peer
dcterms.creatorVoß, Tatjana
dc.relation.doidoi:10.1080/19585969.2024.2359923
dc.subject.swdParaphilieger
dc.subject.swdPädophilieger
dc.subject.swdAgonistger
dc.subject.swdRisikoger
dc.subject.swdRückfallger
dc.subject.swdReduktionger
dc.subject.swdGonadotropin-Releasinghormonger
dc.type.versionpublishedVersion
dcterms.source.identifiereissn:1958-5969
dcterms.source.issueIssue 1
dcterms.source.journalDialogues in Clinical Neuroscienceeng
dcterms.source.pageinfo28 - 37
dcterms.source.volumeVolume 26
kup.iskupfalse


Dateien zu dieser Ressource

Thumbnail
Name:
license_rdf
Größe:
805Bytes
Format:
application/rdf+xml
Öffnen
Thumbnail
Name:
The impact of testosterone_lowering ...
Größe:
963.2Kb
Format:
PDF
Öffnen

Das Dokument erscheint in:

Zur Kurzanzeige

Attribution-NonCommercial-NoDerivatives 4.0 International
Solange nicht anders angezeigt, wird die Lizenz wie folgt beschrieben: Attribution-NonCommercial-NoDerivatives 4.0 International